Antiphospholipid antibodies are a risk factor for venous and arterial thrombosis and may contribute to the development of atherosclerosis...
Keywords: Antiphospholipid antibodies, atherosclerosis, β2-glycoprotein 1, immunization, statins
01/2007 | Thrombosis and Haemostasis, SchattauerCardiovascular diseases, especially ischaemic heart disease, are actually the most frequent causes of death in the Western world and represent a central challenge for modern research and medicine...
Keywords: Akutes Koronarsyndrom, Atherosklerose, Thrombozyten, Myokardinfarkt
01/2006 | Hämostaseologie, SchattauerThe endothelium is of important significance in the development of the acute coronary syndrome. As an endo-/paracrine organ, the endothelium plays a key role in the regulation of the vascular homeostasis...
Keywords: Akutes Koronarsyndrom, Endotheldysfunktion, Stickstoffmonoxid, Atherosklerose
01/2006 | Hämostaseologie, SchattauerOBJECTIVES : Lifestyle has a major influence on the development and progression of atherosclerosis. Our motto for healthy habits is give up one, reduce two, and increase three...
Keywords: atherosclerosis, lifestyle, carotid artery, ultrasonic
01/2005 | Methods of Information in Medicine, SchattauerOBJECTIVES: A new deconvolution method for the analysis of time-resolved laser-induced fluorescence spectroscopy (TR-LIFS) data is introduced and applied for tissue diagnosis...
Keywords: Time-resolved fluorescence spectroscopy, Laguerre deconvolution, atherosclerosis
01/2007 | Methods of Information in Medicine, SchattauerEcholucent carotid plaques are associated with high risk for future ischemic cerebrovascular events independent of the degree of stenosis...
Keywords: atherosclerosis, ultrasound / diagnosis, von Willebrand factor, plasminogen activators, Cerebrovascular disease
07/2006 | Thrombosis and Haemostasis, SchattauerSelective inhibitors of cyclooxygenase (COX)-2 were developed to improve the safety of anti-inflammatory therapy in patients at elevated risk for gastrointestinal complications which are thought to be caused primarily by depression of COX-1 derived mucosal prostanoids...
Keywords: Clinical studies, atherothrombosis, atherosclerosis, inflammation, inflammatory mediators
10/2006 | Thrombosis and Haemostasis, SchattauerEven though non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for a long time, the search continues for anti-inflammatory drugs with few side-effects...
Keywords: atherosclerosis, thrombosis, inflammation, hypercoagulability, coronary syndrome
10/2006 | Thrombosis and Haemostasis, SchattauerIt was the objective of this study to investigate the relation between nitric oxide synthase (NOS3) gene polymorphisms, vascular inflammation, endothelial function, and atherosclerosis...
Keywords: NO synthase gene polymorphisms, inflammation, atherosclerosis, vascular function
10/2006 | Thrombosis and Haemostasis, SchattauerProliferation of fibroblasts is vital for adequate wound healing but is probably also involved in different hyperproliferative disorders such as atherosclerosis and cancer...
Keywords: Fibroblasts, platelets, proliferation, 5-lipoxygenase, atherosclerosis
11/2006 | Thrombosis and Haemostasis, SchattauerAspirin reduces several pro-inflammatory markers in patients with coronary heart disease (CHD), while limited data exists with clopidogrel...
Keywords: antiplatelet agents, inflammation, atherosclerosis, randomized trial
11/2006 | Thrombosis and Haemostasis, SchattauerAlthough lifestyle and environmental factors influence the prevalence of myocardial infarction, genetic epidemiological studies have suggested that several genetic variants increase the risk for this condition...
Keywords: genetics, Polymorphism, myocardial infarction, coronary heart disease, atherosclerosis
08/2006 | Thrombosis and Haemostasis, SchattauerF11R is the gene name for an adhesion protein, called the F11-receptor, aka JAM-A, which under normal physiological conditions is expressed constitutively on the surface of platelets and localized within tight junctions of endothelial cells (EC)...
Keywords: F11R, F11 receptor, F11R/JAM-A, inflammatory thrombosis, atherosclerosis, atherothrombosis
00/0000 | Thrombosis and Haemostasis, SchattauerFibrin network structure has been correlated with coronary disease. Fibrinogen and (FGG and FGA) gene haplotypes (chromosome 4q28) may be associated with fibrin network structure, and thereby with rigidity of the fibrin clot and sensitivity of the fibrin clot to the fibrinolytic system...
Keywords: Coronary disease, atherosclerosis, epidemiology, genetics, fibrinogen
00/0000 | Thrombosis and Haemostasis, SchattauerThe urokinase-type plasminogen activator (uPA), its inhibitor PAI-1 and its cellular receptor (uPAR), play a pivotal role in pericellular proteolysis...
Keywords: Urokinase / receptor, plasminogen activator inhibitors, Angiogenesis and inhibitors, atherosclerosis, restenosis
03/2007 | Thrombosis and Haemostasis, SchattauerThrombomodulin (TM) is an endothelial glycoprotein that functions as a thrombin cofactor in the activation of protein C...
Keywords: arterial remodeling, atherosclerosis, thrombomodulin
04/2007 | Thrombosis and Haemostasis, SchattauerOxidative modification of low-density lipoprotein (LDL) is a pivotal process in early atherogenesis and can be brought about by myeloperoxidase (MPO), which is capable of reacting with nitrite, a NO metabolite...
Keywords: antioxidant, atherosclerosis, cocoa, epicatechin, flavonoids, LDL oxidation, procyanidins
09/2004 | Biological Chemistry, Walter de Gruyter
Keywords: atherosclerosis, CD14, environmental factors, genetic polymorphisms, interleukin-10, myocardial infarction
07/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterCardiovascular diseases are a real public health problem and have multifactorial origin...
Keywords: atherosclerosis, environmental factors, intermediate phenotypes of inflammation, polymorphisms
07/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterSince early after the introduction of serum ?-glutamyltransferase (GGT) in clinical practice as a reliable and widely employed laboratory test, epidemiological and prospective studies have repeatedly shown that this activity possesses a prognostic value for morbidity and mortality...
Keywords: atherosclerosis, glutathione, myocardial infarction, serum ?-glutamyltransferase, Stroke
10/2004 | Clinical Chemical Laboratory Medicine, Walter de GruyterMetabolic conversion of homocysteine (Hcy) to a chemically reactive metabolite, Hcy-thiolactone, catalyzed by methionyl-tRNA synthetase is the first step in a pathway that is suggested to contribute to Hcy toxicity in humans...
Keywords: atherosclerosis, homocysteine-thiolactone, N-homocysteine-protein autoantibodies
10/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterStudies in healthy humans have shown that consumption of conjugated linoleic acid (CLA) significantly reduced very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) blood concentrations...
Keywords: apolipoprotein B100 (apoB100), atherosclerosis, cholesterol, conjugated linoleic acid, HepG2 liver cells, lipoprotein
03/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterFibronectin is a known chemoattractant for several cell types that play a role in the wound healing process, including fibroblasts, endothelial cells and macrophages...
Keywords: atherosclerosis, coronary heart disease, fibronectin, gene polymorphism, plasma fibronectin
01/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: Aspirin, atherosclerosis, hypercholesterolemia, ubiquitin-proteasome system
10/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterAtherosclerosis is widely regarded as a chronic inflammatory disease that develops as a consequence of entrapment of low-density lipoprotein (LDL) in the arterial intima...
Keywords: atherosclerosis, enzymatically modified low-density lipoprotein (E-LDL), lipoproteins, macrophage, oxidized LDL (OxLDL)
12/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterDespite many years of study, clinical trials of new drugs to prevent thrombosis have often been disappointing...
Keywords: atherosclerosis, diabetes, fibrinolysis, nitrosative stress, peroxynitrite, phagocytes
02/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterIncreased C-reactive protein (CRP) concentration within the reference interval (<10.0 mg/L) is a strong predictor of cardiovascular disease (CVD) in apparently healthy adults...
Keywords: atherosclerosis, cardiovascular disease, high-sensitivity C-reactive protein, hsCRP, immunoturbidimetry, Olympus
02/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: angiotensin II type 1 receptor, atherosclerosis, carotid artery, essential hypertension, gene polymorphism
03/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: atherosclerosis, Body mass index, high-sensitivity C-reactive protein, inflammation, neopterin, waist-to-hip ratio
03/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: atherosclerosis, cardio-ankle vascular index, carotid intima-media thickness, folate, homocysteine, young adults
02/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterObesity is thought to be a major determinant in the development of cardiovascular diseases, but the mechanisms whereby enlarged adipose tissue affects vascular function remain poorly defined...
Keywords: atherosclerosis, cathepsin S, obesity
03/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: atherosclerosis, coronary artery disease, diabetes, hydroperoxides, oxidative stress, risk factors
03/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterThere is growing evidence that adiponectin, an adipocytokine with anti-inflammatory and antiathero-genic properties, is involved in the development of atherosclerosis...
Keywords: adiponectin, atherosclerosis, peripheral vascular disease, risk factors
07/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: Atherosklerose, immun-mediierte Entzündung, inflammatorische Biomarker, atherosclerosis, immune-mediated inflammation, inflammatory biomarkers
08/2004 | LaboratoriumsMedizin, Walter de GruyterZusammenfassung Jahrzehnte nach der Erstbeschreibung durch Berg 1963 ist Lipoprotein(a) (Lp(a)) als von den brigen kardiovaskulren Risikofaktoren unabhngiger Risikofaktor anerkannt...
Keywords: Atherosklerose, koronare Herzerkrankung, lipoprotein(a), Plasmalipoproteine, atherosclerosis, coronary heart disease, plasma lipoproteins
06/2007 | LaboratoriumsMedizin, Walter de GruyterZusammenfassung Asymmetrisches Dimethylarginin (ADMA) ist eine endogen produzierte Aminosure, die alle drei Isoformen der Stickoxid-Synthase inhibiert...
Keywords: Asymmetrisches Dimethylarginin (ADMA), Atherosklerose, biomarker, endotheliale Dysfunktion, kardiovaskulres Risiko, Stickstoffmonoxid, atherosclerosis, aymmetric dimethyl arginine (ADMA), cardiovascular risk, coronary artery disease, endothelial dysfunction, nitric oxide
06/2007 | LaboratoriumsMedizin, Walter de Gruyter